Lexeo Therapeutics (LXEO) Invested Capital: 2022-2023
- Lexeo Therapeutics' Invested Capital fell 64.49% to -$162.8 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$162.8 million, marking a year-over-year decrease of 64.49%. This contributed to the annual value of -$113.0 million for FY2022, which is N/A change from last year.
- Latest data reveals that Lexeo Therapeutics reported Invested Capital of -$162.8 million as of Q3 2023, which was down 44.14% from -$113.0 million recorded in Q4 2022.
- In the past 5 years, Lexeo Therapeutics' Invested Capital ranged from a high of -$99.0 million in Q3 2022 and a low of -$162.8 million during Q3 2023.
- For the 2-year period, Lexeo Therapeutics' Invested Capital averaged around -$124.9 million, with its median value being -$113.0 million (2022).
- Data for Lexeo Therapeutics' Invested Capital shows a maximum YoY crashed of 64.49% (in 2023) over the last 5 years.
- Lexeo Therapeutics' Invested Capital (Quarterly) stood at -$113.0 million in 2022, then crashed by 64.49% to -$162.8 million in 2023.
- Its last three reported values are -$162.8 million in Q3 2023, -$113.0 million for Q4 2022, and -$99.0 million during Q3 2022.
